| Metadata stewardship in nanosafety research: Community-driven organisation of metadata schemas to support FAIR nanoscience data AG Papadiamantis, FC Klaessig, TE Exner, S Hofer, N Hofstaetter, ... Nanomaterials 10 (10), 2033, 2020 | 49 | 2020 |
| Special issue on network theory and social housing D Mullins, ML Rhodes Housing, Theory and Society 24 (1), 1-13, 2007 | 47 | 2007 |
| When would immunologists consider a nanomaterial to be safe? Recommendations for planning studies on nanosafety M Himly, M Geppert, S Hofer, N Hofstätter, J Horejs‐Höck, A Duschl Small 16 (21), 1907483, 2020 | 24 | 2020 |
| The impact of nanoparticles on innate immune activation by live bacteria BJ Swartzwelter, AC Fux, L Johnson, E Swart, S Hofer, N Hofstätter, ... International Journal of Molecular Sciences 21 (24), 9695, 2020 | 21 | 2020 |
| Biological effects of allergen–nanoparticle conjugates: uptake and immune effects determined on hAELVi cells under submerged vs. air–liquid interface conditions R Mills-Goodlet, M Schenck, A Chary, M Geppert, T Serchi, S Hofer, ... Environmental Science: Nano 7 (7), 2073-2086, 2020 | 13 | 2020 |
| (Re) Conceptualizing decision-making tools in a risk governance framework for emerging technologies—the case of nanomaterials M Mullins, M Himly, IR Llopis, I Furxhi, S Hofer, N Hofstätter, P Wick, ... Environment Systems and Decisions 43 (1), 3-15, 2023 | 10 | 2023 |
| SARS-CoV-2-laden respiratory aerosol deposition in the lung alveolar-interstitial region is a potential risk factor for severe disease: a modeling study S Hofer, N Hofstätter, A Duschl, M Himly Journal of Personalized Medicine 11 (5), 431, 2021 | 10 | 2021 |
| Biologic effects of nanoparticle-allergen conjugates: time-resolved uptake using an in vitro lung epithelial co-culture model of A549 and THP-1 cells B Grotz, M Geppert, R Mills-Goodlet, S Hofer, N Hofstätter, C Asam, ... Environmental Science: Nano 5 (9), 2184-2197, 2018 | 10 | 2018 |
| Immunotoxicity of nanomaterials in health and disease: Current challenges and emerging approaches for identifying immune modifiers in susceptible populations S Hofer, N Hofstätter, B Punz, I Hasenkopf, L Johnson, M Himly Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 14 (6 …, 2022 | 5 | 2022 |
| Structural alterations of antigens at the material interface: An early decision toolbox facilitating safe-by-design nanovaccine development L Johnson, L Aglas, WT Soh, M Geppert, S Hofer, N Hofstätter, P Briza, ... International Journal of Molecular Sciences 22 (19), 10895, 2021 | 3 | 2021 |
| Mechanistic insights into silica nanoparticle–allergen interactions on antigen presenting cell function in the context of allergic reactions L Johnson, L Aglas, B Punz, HH Dang, C Christ, L Pointner, M Wenger, ... Nanoscale 15 (5), 2262-2275, 2023 | 2 | 2023 |
| Children’s Privilege in COVID-19: The Protective Role of the Juvenile Lung Morphometry and Ventilatory Pattern on Airborne SARS-CoV-2 Transmission to Respiratory Epithelial … N Hofstätter, S Hofer, A Duschl, M Himly Biomedicines 9 (10), 1414, 2021 | 1 | 2021 |
| framework for emerging technologies—the case of nanomaterials M Mullins, M Himly, IR Llopis, I Furxhi, S Hofer, N Hofstätter, P Wick, ... | | 2022 |
| In vitro immuno-nanotoxicological methods that take pre-existing conditions into account M Himly, L Johnson, R Mills-Goodlet, I Hasenkopf, S Hofer, N Hofstaetter, ... Toxicology Letters 350, S20, 2021 | | 2021 |
| A toolbox for early-stage suitability assessment of (nano-) particulate systems in AIT vaccine development L Johnson, L Aglas, WT Soh, M Geppert, S Hofer, N Hofstätter, P Briza, ... 15th World Immune Regulation Meeting 2021, 2021 | | 2021 |
| Studying the stages of immune activation/modulation by silica nanoparticle-allergen conjugates: applying the AOP concept to immunotherapy development L Johnson, L Aglas, M Geppert, S Hofer, N Hofstätter, WT Soh, F Ferreira, ... NanoSafe Digital Conference 2020, 2020 | | 2020 |
| Metadata stewardship in nanosafety research: towards FAIR data implementation and a digital single market AG Papadiamantis, FC Klaessig, TE Exner, S Hofer, N Hofstätter, M Himly, ... Nanomaterials, 2020 | | 2020 |
| Silica nanoparticles as novel adjuvant for allergen-specidic immunotherapy: impact on allergen processing L Johnson, L Aglas, M Geppert, S Hofer, N Hofstätter, WT Soh, P Briza, ... EAACI Congress 2020, 2020 | | 2020 |
| Raw data and heat maps of ARAP deposition modeling S Hofer, N Hofstätter, M Himly Zenodo, 2020 | | 2020 |
| Nanoparticle Dosimetry and Particokinetics: Delivered Dose Prediction in vitro–not without Consideration of Effective Density S Hofer, N Hofstätter, M Geppert, RD Mills-Goodlet, MMH Schenck, ... 12th International Particle Toxicology Conference, 2019 | | 2019 |
Martin HimlyUniversity of Salzburg, Dept Biosciences & Medical BiologyBestätigte E-Mail-Adresse bei plus.ac.at
